MyAverix Finance
SHG · Healthcare
BeiGene Ltd. (688235)
Biotechnology
BeiGene Ltd. (688235) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $335.77B, P/E ratio is 178.99, net margin is 5.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688235
BeiGene Ltd. (688235) — FAQ
What is BeiGene Ltd.'s market cap?
BeiGene Ltd. (688235) has a reported market cap of $335.77B (data as of 2026-03-29).
What is 688235's P/E ratio?
The price-to-earnings (P/E) ratio for BeiGene Ltd. (688235) is 178.99 (data as of 2026-03-29).
Does BeiGene Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for BeiGene Ltd. (688235). Check the MyAverix Finance app for the latest dividend data.
What sector is BeiGene Ltd. in?
BeiGene Ltd. (688235) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688235 listed on?
688235 is listed on SHG.
What is BeiGene Ltd.'s net margin?
BeiGene Ltd. (688235) reports a net margin of 5.4% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.